Back

The impact of prediuretic urine osmolarity and urine osmolarity change on long-term outcomes in acute heart failure patients during early decongestion

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Congestion and heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Mateusz Guzik

Wroclaw Medical University, Wroclaw (Poland)

6 More presentations in this session

Presentation thumbnail
Prognostic assessment of the combination of subclinical congestion parameters in worsening heart failure events and 90-day mortality
Ms L. Burgos (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Preventing heart failure decompensation with non-invasive remote cardiac pressure monitoring: a real-world study preliminary results
Professor A. Bohm (Bratislava, SK)
Abstract Slides Video
Presentation thumbnail
Redefining Nohria's clinical profile classification in acute heart failure with bedside ultrasound: the ITV/VExUS index - a call for new directions
Doctor O. Ruiz Fuentes (Mexico City, MX)
Abstract Slides Video
Presentation thumbnail
Worsening renal function in acute heart failure: the impact on subsequent kidney function and its association with haemoconcentration
Doctor Y. Watanabe (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Rescue ultrafiltration indication in acute heart failure hospitalizations: time trends in temporary use, predictors and clinical implications.
Doctor L. Favaloro (Buenos Aires, AR)
Abstract Slides

Access the full session

Session thumbnail
Congestion and heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Diuretic strategies across the spectrum of acute heart failure: the thin red line between decongestion and acute kidney injury
thumbnail
Congress Session
New tools to detect and treat acute heart failure
thumbnail
Congress Session
Pharmacotherapy for worsening heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources